CONVERGE Post-Approval Study (PAS)
Public ClinicalTrials.gov record NCT05393180. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Hybrid Convergent of Epicardial and Endocardial RF Ablation for the Treatment of Symptomatic Longstanding Persistent AF
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of CONVERGE PAS is to evaluate clinical outcomes (peri-procedural and long-term) in a cohort of patients treated during commercial use of the EPi-Sense® Guided Coagulation System or EPi-Sense ST™ Coagulation System to treat symptomatic long-standing persistent atrial fibrillation (AF) patients who are refractory or intolerant to at least one Class I and/or III AAD.
Study identification
- NCT ID
- NCT05393180
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 53 participants
Conditions and interventions
Conditions
Interventions
- Epicardial And Endocardial RF Ablation For The Treatment Of Symptomatic Long-standing Persistent AF Device
Device
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 13, 2022 (Actual)
- Primary completion
- Feb 26, 2027 (Estimated)
- Completion
- Nov 21, 2028 (Estimated)
- Last update posted
- Nov 6, 2026
2022 – 2028
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sutter Bay Hospitals | San Francisco | California | 94107 | — |
| Hartford Hospital | Hartford | Connecticut | 06102 | — |
| Baycare Health Systems | Clearwater | Florida | 33759 | — |
| Orlando Health | Orlando | Florida | 32806 | — |
| Emory Saint Joseph Hopsital | Atlanta | Georgia | 30322 | — |
| Wellstar Health System | Marietta | Georgia | 30062 | — |
| Norton Heart & Vascular Institute | Louisville | Kentucky | 40205 | — |
| MedStar Union Memorial Hospital | Baltimore | Maryland | 21218 | — |
| Southcoast Hospitals Group | New Bedford | Massachusetts | 02740 | — |
| AtlantiCare Medical Center | Atlantic City | New Jersey | 08401 | — |
| Avera Heart Hospital of SD | Sioux Falls | South Dakota | 57108 | — |
| University of Utah | Salt Lake City | Utah | 84112 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05393180, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 6, 2026 · Synced Nov 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05393180 live on ClinicalTrials.gov.